抗不安薬市場：タイプ、剤形、投与経路、適応症、流通チャネル別-2025-2030年の世界予測

抗不安薬市場は、2023年に12億4,000万米ドルと評価され、2024年には13億2,000万米ドルに達すると予測され、CAGR 7.27％で成長し、2030年には20億3,000万米ドルに達すると予測されています。

主に不安症状を緩和するために開発された薬や介入策を含む抗不安薬市場は、メンタルヘルス意識の高まり、不安障害の有病率の増加、進行中の医薬品の進歩によって決定的に形成されたダイナミックな分野で活動しています。抗不安薬の必要性は、不安障害が数百万人に影響を及ぼし、ベンゾジアゼピン、SSRI、SNRI、非定型抗精神病薬や自然療法などの新規治療薬を含む多様な薬理学的解決策が必要とされている、世界のメンタルヘルス危機の高まりによって強調されています。その用途は、全般性不安障害の治療からうつ病管理やPTSDの補助薬まで広範囲に及び、その汎用性は個別化された患者ケアに不可欠です。最終用途の範囲は、精神科施設、病院、外来患者ケアの設定にまたがっており、急性および慢性治療レジメンへの重要な統合を反映しています。市場成長は、ヘルスケア支出の増加、ドラッグデリバリー・システムの技術的進歩、アクセシビリティを高める遠隔医療サービスの急速な拡大といった要因に大きく影響されています。さらに、新興国市場におけるメンタルヘルスケアに対する認識と受容の高まりは、有望な市場拡大機会をもたらしています。しかし、厳しい規制の枠組み、高額な治療費、ベンゾジアゼピンなどの特定の抗不安薬に関連する乱用や依存の可能性などが成長の課題となっています。技術革新の主な分野としては、非中毒性抗不安薬の開発、ゲノミクスを活用した個別化医療アプローチ、医薬品による介入を補完することを目的としたデジタル治療薬などが挙げられます。また、神経調節やカンナビノイドをベースとしたソリューションに関する最先端の研究も、市場発展の可能性を提供しています。競合情勢は厳しいが、製薬企業と研究機関との継続的なパートナーシップは、規制上のハードルを乗り越え、薬効を最適化する道筋を提供します。市場の性質は、科学的進歩、社会的認識の変化、効果的なメンタルヘルス・ソリューションに対する永続的な需要に後押しされ、弾力的かつ適応的です。これらの洞察は、成長を持続させるためにイノベーションをターゲットとし、既存の課題に対処する積極的なアプローチを強調するものです。

市場力学：急速に進化する抗不安薬市場の主要市場インサイトを公開

抗不安薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 不安障害の有病率の増加、メンタルヘルスと治療に対する意識の高まり
  • 麻酔における鎮静剤としての抗不安薬の登場
• 市場抑制要因
  • 抗不安薬の長期使用による副作用の問題
• 市場機会
  • 医薬品分野における抗不安薬の技術的進歩
  • メンタルヘルスとウェルビーイングを促進するための政府イニシアチブの増加
• 市場の課題
  • 精神障害に関連する社会的スティグマに関する問題

ポーターのファイブフォース：抗不安薬市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：抗不安薬市場における外部からの影響の把握

外部マクロ環境要因は、抗不安薬市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析抗不安薬市場における競合情勢の把握

抗不安薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス抗不安薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、抗不安薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨抗不安薬市場における成功への道筋を描く

抗不安薬市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 不安障害の有病率の増加とメンタルヘルスと治療に関する意識の向上
    • 麻酔における鎮静剤としての抗不安薬の出現
  • 抑制要因
    • 抗不安薬の長期使用による副作用に関連する問題
  • 機会
    • 医薬品分野における抗不安薬の技術的進歩
    • メンタルヘルスとウェルビーイングを促進するための政府の取り組みの強化
  • 課題
    • 精神障害に関連する社会的偏見に関する問題
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 抗不安薬市場：タイプ別

• 抗うつ薬
• 抗ヒスタミン薬
• アザピロン
• ベンゾジアゼピン
• ベータ遮断薬
• 非ベンゾジアゼピン
• 鎮静催眠薬

第7章 抗不安薬市場：形態別

• カプセル
• タブレット

第8章 抗不安薬市場：投与経路別

• オーラル
• 非経口

第9章 抗不安薬市場適応症別

• 全般性不安障害
• パニック障害
• 恐怖症
• 心的外傷後ストレス障害（PTSD）

第10章 抗不安薬市場：流通チャネル別

• オフライン
• オンライン

第11章 南北アメリカの抗不安薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の抗不安薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの抗不安薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AbbVie Inc.
• Accord Healthcare US
• Akorn Operating Company LLC
• Alvogen
• Amneal Pharmaceuticals LLC
• Apotex Inc.
• AstraZeneca PLC
• Bausch Health Companies Inc.
• Dellwich Healthcare LLP
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline PLC
• H. Lundbeck A/S
• Hameln Pharma GmbH
• Hikma Pharmaceuticals PLC
• Johnson & Johnson Services, Inc.
• Lifecare Neuro Products Limited
• Lifegenix
• Neurocon Inc.
• Noreva Biotech
• Novartis AG
• Pfizer Inc.
• Sanofi S.A.
• Sun Pharmaceutical Industries Ltd.

LIST OF FIGURES

• FIGURE 1. ANXIOLYTICS MARKET RESEARCH PROCESS
• FIGURE 2. ANXIOLYTICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ANXIOLYTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ANXIOLYTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ANXIOLYTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ANXIOLYTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ANXIOLYTICS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ANXIOLYTICS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL ANXIOLYTICS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL ANXIOLYTICS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES ANXIOLYTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES ANXIOLYTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. ANXIOLYTICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. ANXIOLYTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ANXIOLYTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ANXIOLYTICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ANXIOLYTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ANXIOLYTICS MARKET DYNAMICS
• TABLE 7. GLOBAL ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ANXIOLYTICS MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ANXIOLYTICS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ANXIOLYTICS MARKET SIZE, BY AZAPIRONES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ANXIOLYTICS MARKET SIZE, BY BENZODIAZEPINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ANXIOLYTICS MARKET SIZE, BY BETA-BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ANXIOLYTICS MARKET SIZE, BY NONBENZODIAZEPINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ANXIOLYTICS MARKET SIZE, BY SEDATIVE-HYPNOTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ANXIOLYTICS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ANXIOLYTICS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL ANXIOLYTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL ANXIOLYTICS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL ANXIOLYTICS MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL ANXIOLYTICS MARKET SIZE, BY PANIC DISORDER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL ANXIOLYTICS MARKET SIZE, BY PHOBIAS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL ANXIOLYTICS MARKET SIZE, BY POSTTRAUMATIC STRESS DISORDER (PTSD), BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL ANXIOLYTICS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL ANXIOLYTICS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 45. CANADA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. CANADA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 47. CANADA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 48. CANADA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 49. CANADA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES ANXIOLYTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 71. AUSTRALIA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 72. CHINA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. CHINA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 74. CHINA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 75. CHINA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 76. CHINA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 77. INDIA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. INDIA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 79. INDIA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 80. INDIA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 81. INDIA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 86. INDONESIA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 91. JAPAN ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 96. MALAYSIA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 101. PHILIPPINES ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 106. SINGAPORE ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 111. SOUTH KOREA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 116. TAIWAN ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 121. THAILAND ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 126. VIETNAM ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 137. DENMARK ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 142. EGYPT ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 147. FINLAND ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 152. FRANCE ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 157. GERMANY ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 162. ISRAEL ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 163. ITALY ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 164. ITALY ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 165. ITALY ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 166. ITALY ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 167. ITALY ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 172. NETHERLANDS ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 177. NIGERIA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 182. NORWAY ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 183. POLAND ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 184. POLAND ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 185. POLAND ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 186. POLAND ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 187. POLAND ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 188. QATAR ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 189. QATAR ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 190. QATAR ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 191. QATAR ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 192. QATAR ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 197. RUSSIA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 202. SAUDI ARABIA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 207. SOUTH AFRICA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 212. SPAIN ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 217. SWEDEN ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 222. SWITZERLAND ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 227. TURKEY ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 232. UNITED ARAB EMIRATES ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 237. UNITED KINGDOM ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 238. ANXIOLYTICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 239. ANXIOLYTICS MARKET, FPNV POSITIONING MATRIX, 2023

The Anxiolytics Market was valued at USD 1.24 billion in 2023, expected to reach USD 1.32 billion in 2024, and is projected to grow at a CAGR of 7.27%, to USD 2.03 billion by 2030.

The anxiolytics market, which encompasses medications and interventions primarily developed to alleviate anxiety symptoms, operates in a dynamic field critically shaped by rising mental health awareness, increasing prevalence of anxiety disorders, and ongoing pharmaceutical advancements. The necessity for anxiolytics is underscored by the mounting global mental health crisis, with anxiety disorders impacting millions and necessitating a diverse range of pharmacological solutions that include benzodiazepines, SSRIs, SNRIs, and novel therapeutics like atypical antipsychotics and natural remedies. Their applications are extensive, ranging from generalized anxiety disorder treatment to adjuncts in depression management and PTSD, making their versatility essential for personalized patient care. The end-use scope spans across psychiatric facilities, hospitals, and outpatient care settings, reflecting their critical integration into both acute and chronic treatment regimens. Market growth is significantly influenced by factors such as increasing healthcare expenditure, technological advancements in drug delivery systems, and the rapid expansion of telehealth services, which enhance accessibility. Additionally, burgeoning awareness and acceptance of mental health care in developing regions present promising market expansion opportunities. However, growth is challenged by stringent regulatory frameworks, high costs of treatment, and potential abuse and dependency associated with certain anxiolytics like benzodiazepines. Key areas for innovation include the development of non-addictive anxiolytics, personalized medicine approaches leveraging genomics, and digital therapeutics aimed at complementing pharmaceutical interventions. Cutting-edge research into neuromodulation and cannabinoid-based solutions also offers potential avenues for market evolution. While the market landscape is competitive, ongoing partnerships between pharmaceutical companies and research institutions offer pathways to navigate regulatory hurdles and optimize drug efficacy. The nature of the market is both resilient and adaptive, driven by scientific progression, shifting societal perceptions, and an enduring demand for effective mental health solutions. These insights underscore a proactive approach in targeting innovations and addressing existing challenges to sustain growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Anxiolytics Market

The Anxiolytics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of anxiety disorders among people and awareness about mental health and treatment
  • Emergence of anxiolytics as sedative agents in anesthesia
• Market Restraints
  • Problems associated with side effects after prolonged use of anxiolytics
• Market Opportunities
  • Technical advancement of anxiolytic drugs in pharmaceutical sector
  • Increasing government initiatives to promote mental health and wellbeing
• Market Challenges
  • Problems related to social-stigma associated with mental disorders

Porter's Five Forces: A Strategic Tool for Navigating the Anxiolytics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Anxiolytics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Anxiolytics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Anxiolytics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Anxiolytics Market

A detailed market share analysis in the Anxiolytics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Anxiolytics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Anxiolytics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Anxiolytics Market

A strategic analysis of the Anxiolytics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Anxiolytics Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Accord Healthcare US, Akorn Operating Company LLC, Alvogen, Amneal Pharmaceuticals LLC, Apotex Inc., AstraZeneca PLC, Bausch Health Companies Inc., Dellwich Healthcare LLP, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, H. Lundbeck A/S, Hameln Pharma GmbH, Hikma Pharmaceuticals PLC, Johnson & Johnson Services, Inc., Lifecare Neuro Products Limited, Lifegenix, Neurocon Inc., Noreva Biotech, Novartis AG, Pfizer Inc., Sanofi S.A., and Sun Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Anxiolytics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Antidepressants, Antihistamines, Azapirones, Benzodiazepines, Beta-blockers, Nonbenzodiazepines, and Sedative-hypnotics.
• Based on Form, market is studied across Capsules and Tablets.
• Based on Route of Administration, market is studied across Oral and Parenteral.
• Based on Indication, market is studied across Generalized Anxiety Disorder, Panic Disorder, Phobias, and Posttraumatic Stress Disorder (PTSD).
• Based on Distribution Channel, market is studied across Offline and Online.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of anxiety disorders among people and awareness about mental health and treatment
    • 5.1.1.2. Emergence of anxiolytics as sedative agents in anesthesia
  • 5.1.2. Restraints
    • 5.1.2.1. Problems associated with side effects after prolonged use of anxiolytics
  • 5.1.3. Opportunities
    • 5.1.3.1. Technical advancement of anxiolytic drugs in pharmaceutical sector
    • 5.1.3.2. Increasing government initiatives to promote mental health and wellbeing
  • 5.1.4. Challenges
    • 5.1.4.1. Problems related to social-stigma associated with mental disorders
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Anxiolytics Market, by Type

• 6.1. Introduction
• 6.2. Antidepressants
• 6.3. Antihistamines
• 6.4. Azapirones
• 6.5. Benzodiazepines
• 6.6. Beta-blockers
• 6.7. Nonbenzodiazepines
• 6.8. Sedative-hypnotics

7. Anxiolytics Market, by Form

• 7.1. Introduction
• 7.2. Capsules
• 7.3. Tablets

8. Anxiolytics Market, by Route of Administration

• 8.1. Introduction
• 8.2. Oral
• 8.3. Parenteral

9. Anxiolytics Market, by Indication

• 9.1. Introduction
• 9.2. Generalized Anxiety Disorder
• 9.3. Panic Disorder
• 9.4. Phobias
• 9.5. Posttraumatic Stress Disorder (PTSD)

10. Anxiolytics Market, by Distribution Channel

• 10.1. Introduction
• 10.2. Offline
• 10.3. Online

11. Americas Anxiolytics Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Anxiolytics Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Anxiolytics Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AbbVie Inc.
• 2. Accord Healthcare US
• 3. Akorn Operating Company LLC
• 4. Alvogen
• 5. Amneal Pharmaceuticals LLC
• 6. Apotex Inc.
• 7. AstraZeneca PLC
• 8. Bausch Health Companies Inc.
• 9. Dellwich Healthcare LLP
• 10. Eli Lilly and Company
• 11. F. Hoffmann-La Roche Ltd.
• 12. GlaxoSmithKline PLC
• 13. H. Lundbeck A/S
• 14. Hameln Pharma GmbH
• 15. Hikma Pharmaceuticals PLC
• 16. Johnson & Johnson Services, Inc.
• 17. Lifecare Neuro Products Limited
• 18. Lifegenix
• 19. Neurocon Inc.
• 20. Noreva Biotech
• 21. Novartis AG
• 22. Pfizer Inc.
• 23. Sanofi S.A.
• 24. Sun Pharmaceutical Industries Ltd.